Comprehensive Graduate program
Become a Leader in a Growing Global Field
Become a leader in this fast-growing global field by enrolling in the University of Florida's Applied Pharmacoeconomics specialty track.
What is Applied Pharmacoeconomics?
Pharmacoeconomics is an aid to better health care management.
Fast-Growing & Globally Important
Pharmacoeconomics utilizes economic methods to evaluate and compare the value of one drug or intervention to another. With serious concerns about the value and cost of drugs and health care, and continuing pressure to reduce budgets, everyone asks, “Where should I spend health care dollars to get the most value?” Pharmacoeconomics answers this question.
A Key to Better Health Care Outcomes
Pharmacoeconomics and its related health economics and outcomes research (HEOR) fields provide insights that guide optimal resource allocation. Pharmacoeconomic data are used by clinicians, health systems, health insurers and payers, policy-makers, health technology assessment agencies, and patients. This exciting area of study identifies quality patient care by balancing economic, humanistic and clinical outcomes, taking the emphasis away from “what’s the cheapest?”
Selected curriculum topics include:
- Economic valuation methods
- Health policy & technology assessment
- Outcomes measurement
- Data analytic techniques & presentation of results
- Drug pricing & reimbursement
- Health & prescription drug benefit design
- Micro- & macroeconomics
Top Education from a Top University
This applied pharmacoeconomics graduate program is one of the few accredited online graduate programs in the United States where you will get a comprehensive, applied and real-world education in this unique and in-demand area of study.
Meet the Track Director
Dr. Mikael Svensson
The Applied Pharmacoeconomics track is led by Mikael Svensson, Ph.D., a health economist and pharmacoeconomist specializing in comparative – and cost-effectiveness analyses, causal inference and policy evaluation. Dr. Svensson joined the University of Florida Department of Pharmaceutical Outcomes & Policy during Fall 2022, and has previously taught health economics internationally and within the US.